Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra. The state of the law on psychedelic substances is in flux. 10; 312.80-88;

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” With the increasing decriminalization of medical cannabis, more and more military veterans have turned to the plant for help.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

MARCH 2, 2020

Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. In lockstep with the FDA’s more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Veriheal

JUNE 29, 2021

This Act permits individuals that have been diagnosed with life-threatening conditions or diseases that have exhausted all other approved treatment and therapeutic options that are also unable to participate in clinical trials the ability to access certain treatments that would otherwise be unapproved for access.

Therapy 53

Therapy DEA Patients Clinical Trials 53

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. However, the AAFP supports decriminalization of possession of marijuana for personal use. The World Health Organization (WHO) reports approximately 2.5% In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. Some states that have passed recreational or medical marijuana legislation are still negotiating the details for implementing these programs.

Recreational 52

Recreational Data Cannabis DEA 52

Canna Law Blog

NOVEMBER 16, 2021

Mace’s bill, while decriminalizing cannabis completely and getting it off of schedule I, would also have the Feds regulate cannabis like alcohol while deferring ultimately to the states on licensing and other commercial regulations. The enforcement role moves from DEA to ATF. International law and treaties.

DEA 87

DEA Business Banking Food 87

Veriheal

MAY 13, 2022

In particular, there has been a rapid increase in efforts to decriminalize (or even legalize) various psychedelic substances , such as mescaline. According to the Drug Enforcement Administration (DEA) website , magic mushrooms are recognizable by their slender stems, which are “topped by caps with dark gills on the underside.”

Research and Development 90

Research and Development Legalization Consumption Microdosing 90

Veriheal

OCTOBER 23, 2020

She also states that they’ve been able to propose solutions on a wide spectrum towards decriminalization and legalization, and that is increasingly becoming a position that more Republicans are agreeable to. House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. .

DEA 52

DEA Dispensary Programs Policy 52

Veriheal

OCTOBER 23, 2020

She also states that they’ve been able to propose solutions on a wide spectrum towards decriminalization and legalization, and that is increasingly becoming a position that more Republicans are agreeable to. House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. .

DEA 52

DEA Dispensary Programs Policy 52

Cannabis Law Report

JANUARY 14, 2020

Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research. The MORE Act would decriminalize marijuana and THC at the federal level by removing it from Schedule I of the Controlled Substances Act, which currently classifies it as an addictive drug that has no accepted medical use, akin to heroin. Volkow, M.D.

Clinical Trials 69

Clinical Trials Programs Access DEA 69